Polymorphisms and Plasma Levels of IL-27: Impact on Genetic Susceptibility and Clinical Outcome of Bladder Cancer

BMC Cancer - United Kingdom
doi 10.1186/s12885-015-1459-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Contribution of Activated Platelets to Plasma IL-27 Levels

Critical Care
Critical CareIntensive Care Medicine
2013English

Ten Genetic Polymorphisms in Bladder Cancer.

Journal of Medical Genetics
Genetics
1983English

Genetic Polymorphisms Underlying Lung Cancer Susceptibility and Therapeutic Response

Genes and Environment
Social PsychologyGeneticsEnvironmental Science
2012English

IL-6 Gene Promoter Polymorphisms: Genetic Susceptibility to Recurrent Pregnancy Loss

Bratislava Medical Journal
2014English

Clinical, Prognostic, and Therapeutic Significance of Heat Shock Protein 27 in Bladder Cancer

Oncotarget
Oncology
2018English

ID:2028 PLASMA LEVELS OF MMPs AND TIMP-1 IN BLADDER CANCER PATIENTS

Biomedical Research and Therapy
BiochemistryMedicineGeneticsMolecular Biology
2017English

Single Nucleotide Polymorphisms in IL-10, IL-12p40, and IL-13 Genes and Susceptibility to Glioma

International Journal of Medical Sciences
Medicine
2015English

Clinical Profile and Outcome of Gall Bladder Carcinoma

International Journal of Advanced Multidisciplinary Research
2017English

Genetic Polymorphisms and Oral Cancer

Journal of UOEH
MedicineEnvironmentalPublic HealthOccupational Health
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy